Holen Sie sich die Stockscreener-App
6.02
0.00%
0.00
Myriad Genetics Inc Aktie (MYGN) Neueste Nachrichten
Labcorp to buy Myriad’s prenatal health testing unit for $210M - MedTech Dive
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers - The Manila Times
Myriad Genetics presents data on cancer recurrence detection test By Investing.com - Investing.com Canada
Myriad Genetics releases MRD cancer detection data at ESMO 2026 - StreetInsider
Myriad Genetics (MYGN) Stock Sees Fair Value Lift After Split Analyst Revisions - Yahoo Finance
Myriad Genetics: Prenatal Sale Provides A Lifeline In A Tough Spot (NASDAQ:MYGN) - Seeking Alpha
Stocks making big moves yesterday: Washington Trust Bancorp, Doximity, Myriad Genetics, Arhaus, and Gartner - Yahoo Finance
Myriad Genetics to present at Wells Fargo healthcare conference - scanx.trade
Myriad Genetics, Inc. (MYGN) stock price, news, quote and history - Yahoo Finance Singapore
Stocks making big moves yesterday: Washington Trust Bancorp, Doximity, Myriad Genetics, Arhaus, and Gartner - FinancialContent
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why - Yahoo Finance
Form 8K Myriad Genetics Inc For: 20 October By Investing.com - Investing.com Nigeria
Molecular Diagnostic Stock Myriad Genetics (NASDAQ: MYGN) Gains on News of Selling Prenatal Health Testing Business - Investorideas.com
Why Is Myriad Genetics Stock Trading Higher Today?Myriad Genetics (NASDAQ:MYGN) - Benzinga
Current ratio of Myriad Genetics, Inc. – XETR:MYD - TradingView
Myriad Genetics stock surges on $210M prenatal unit sale - Yahoo Finance Singapore
Myriad Genetics stock surges on $210M prenatal unit sale - Investing.com
Myriad Genetics (MYGN) Shares Surge 20% Premarket on Prenatal He - GuruFocus
Hasbro Posts Upbeat Q3 Earnings, Joins Myriad Genetics, Equifax And Other Big Stocks Moving Higher On Tuesday - Benzinga
Myriad Genetics to Sell Prenatal Testing Business to Labcorp for $210M - GenomeWeb
Myriad to sell prenatal health business to Labcorp (MYGN:NASDAQ) - Seeking Alpha
MYGN Stock Draws Bullish Targets As Prostate Cancer Push Builds - Timothy Sykes
MYGN Stock Draws Bullish Targets As Oncology Pivot Accelerates - StocksToTrade
Why is Myriad Genetics stock surging today? - Investing.com
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp - The Manila Times
Form 8K Myriad Genetics Inc For: 20 October By Investing.com - Investing.com India
Myriad Genetics to Sell Prenatal Health Division to LabCorp for $210 Million Cash - Kalkine Media
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp - Yahoo Finance
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know - Yahoo Finance
Myriad Genetics, Inc. (MYGN) Stock Forecasts - Yahoo Finance
Myriad Genetics to report Q3FY26 results on November 4, 2026 - scanx.trade
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 - Yahoo Finance
What Myriad Genetics Doubters Saw Before The Drop - Yahoo Finance
SOPHiA GENETICS, Myriad Genetics and AstraZeneca Collaborate to Advance Precision Oncology in Prostate Cancer - BioPharma APAC
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology - PR Newswire
MYRIAD GENETICS INC MYRIAD GENE (0K3W.L) Q2 FY2026 earnings call transcript - Yahoo Finance
Craig-Hallum raises target for Myriad Genetics stock from USD 4.00 to USD 8.00 - AD HOC NEWS
Craig-Hallum raises target for Myriad Genetics stock from USD 4.00 to USD 8.00 - AD HOC NEWS
Myriad Genetics, Inc. (0K3W.L) stock price, news, quote and history - Yahoo Finance UK
Myriad Genetics (MYGN) Stock Sees Fair Value Lift As Analysts Weigh Split Targets - Yahoo Finance
Myriad Genetics (Nasdaq:MYGN)Stock Analysis - Simply Wall Street
Why Is Myriad Genetics (MYGN) Stock Soaring Today - FinancialContent
Why Is Myriad Genetics (MYGN) Stock Soaring Today - Yahoo Finance
Myriad Genetics, Inc. (MYGN) Stock Forecasts - Yahoo Finance
Form 4 Myriad Genetics Inc For: 27 September By Investing.com - Investing.com South Africa
Global Paternity & Relationship Testing Services Market Set for Growth Through 2030 as DNA Testing Demand Expands Across Applications and Product Segments - GlobeNewswire Inc.
Myriad Genetics (MYGN) ex-CCO keeps stock-tied PSUs - Stock Titan
Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating the Challenges in Diagnostics & Research - DirectorsTalk Interviews
Myriad Genetics (MYGN) Stock Fair Value Moves Lower After Analyst Cuts And Guidance Reset - Yahoo Finance
Myriad Genetics (NASDAQ: MYGN) swaps commercial chief but keeps 2026 outlook - Stock Titan
0.59%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):